Skip to main content
. 2021 Jan 20;88(4):828–837. doi: 10.1093/neuros/nyaa544

TABLE 1.

Demographic and Clinical Characteristics of the Study Patients (n = 438)

Gender, n (%)
 Men 99 (23%)
 Women 339 (77%)
Age (yr)
 Median [range]; mean ± SD 51 [15-83]; 51.13 ± 12.28
Karnofsky Performance Index before SRS (score)
 Median [range]; mean ± SD 90 [50-100]; 85.31 ± 13.97
 Data not reported 244 (56%)
Pre-SRS visual deficit, n (%)
 Yes 257 (59%)
 No 181 (41%)
Other presenting symptoms, na
 Headache 85
 Diplopia 43
 Ptosis 41
 Incidental 35
 Seizure 18
 Other 62
Duration of symptoms (mo)
 Median [range]; mean ± SD 10 [0-240]; 19.60 ± 30.23
 Unknown or data not available 71 (16%)
Pre-SRS endocrinopathy, n (%)
 None 412 (94%)
 Hypothyroidism 15 (3%)
 Estrogen/testosterone deficiency 3 (1%)
 Diabetes insipidus 1 (0%)
 Not reported 7 (2%)
Nearest distance to the optic apparatus (mm)
 Median [range]; mean ± SD 0 [0-2.3]; 0.36 ± 0.67
 In direct contact with optic pathway 328 (75%)
Meningioma principal location, n (%)
 Clinoid 191 (44%)
 Tuberculum sella 136 (31%)
 Sphenoid wing 31 (7%)
 Planum sphenoidale 17 (4%)
 Clival/petroclival 15 (3%)
 Parasellar 10 (2%)
 Suprasellar 8 (2%)
 Intraorbital 4 (1%)
 Intrasellar 2 (1%)
 Optic sheath 1 (0%)
 Temporal pole 1 (0%)
 Frontobasal 1 (0%)
 Optic nerve sheath 1 (0%)
 Not specified/other 8 (2%)
Other meningiomas, n (%) 77 (8%)
Index meningioma surgery before SRS, n (%) 153 (35%)
Number of prior resections, n (%)
 1 121 (79%)
 2 28 (18%)
 3 3 (2%)
 4 1 (1%)
Type of prior resection, n (%)
 Gross total resection 21 (14%)
 Subtotal resection 120 (79%)
 Biopsy 9 (6%)
 Data not available 2 (1%)
Interval between surgery and SRS (mo)
 Median [range]; mean ± SD 9 [1-246]; 28.32 ± 44.57
Meningioma WHO grade, n (%)
 I 124 (28%)
 II 2 (1%)
 No pre-SRS surgery or data not available 312 (71%)
Histological type of index meningioma, n (%)
 Meningothelial 30 (7%)
 Transitional 28 (6%)
 Psammomatous 10 (2%)
 Fibroblastic 5 (1%)
 Mixed transitional and fibroblastic 5 (1%)
 Angiomatous 1 (0.2%)
 Microcystic 1 (0.2%)
 Secretory 1 (0.2%)
 Atypical 1 (0.2%)
 No pre-SRS surgery or data not available 356 (81%)
Pre-SRS fractionated radiation therapy, n (%) 10 (2%)
Pre-SRS radiation therapy dose (Gy)
 Median [range]; mean ± SD 45 [13-60]; 40.42 ± 18.15
 Data not available 4 (40%)
Pre-SRS radiation therapy number of fractions
 Median [range]; mean ± SD 17 [1-30]; 15.67 ± 12.21
 Data not available 4 (40%)

SD, standard deviation.

aTotal number does not add up to 438 because some patients had more than 1 presenting symptom.